Is AbbVie Stock a Buy Now?
The company is grappling with losing Humira’s patent protection in 2023.
Mindfully Curated
The company is grappling with losing Humira’s patent protection in 2023.
Dutch Bros is stirring up the coffee industry as a rapidly growing up-and-comer.
Diversification isn’t always a good thing.
Medical Properties Trust is not getting paid all the rent due from a large tenant.
Look for companies that are dominating a simple market that will always have plenty of customers.
DraftKings was one of the market’s best performers last year, defying skeptics. Can the stock keep it up?
PC gaming is escaping the Windows ecosystem.
A decade is a long time in the tech world.
You may receive less than you expect in benefits thanks to this rule.
Ark analysts think this could be the driving force behind AI-powered productivity improvements.
The market has been thriving, but how long might that last?
Will the cybersecurity giant continue to outperform the leader in e-signature services?
Here’s how a humble apple butter business became an $8 billion powerhouse.
Diamondback Energy recently sent its investors a lot more cash.
Buyers aren’t the ones funding Etsy’s expansion plans.
This New Year’s resolution will pay you for years to come.
Ford is managing the transition to EVs prudently.
This bank is priced 37% below its book value. Here’s why it deserves a look from investors.
It’s a great option if it happens to be available to you.
This innovative company avoided bankruptcy in 2023, but that doesn’t mean it’s a good stock to hold.